Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1686
|
635
|
0.100 |
None |
1.000 |
11 |
|
2005 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10153
|
1571
|
0.100 |
None |
1.000 |
11 |
|
1992 |
2019 |
Virus Diseases
|
group |
Infections
|
Disease or Syndrome
|
1469
|
42
|
0.100 |
None |
1.000 |
10 |
|
2003 |
2019 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2890
|
352
|
0.080 |
None |
1.000 |
8 |
|
1993 |
2019 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1679
|
213
|
0.070 |
None |
1.000 |
7 |
|
2009 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.040 |
None |
1.000 |
4 |
|
1996 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8577
|
1441
|
0.040 |
None |
1.000 |
4 |
|
1996 |
2019 |
Lupus Erythematosus, Discoid
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
547
|
46
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2013 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1105
|
238
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2020 |
Lupus Erythematosus
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
557
|
44
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2013 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2018 |
Lupus Vulgaris
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
525
|
44
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2013 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6241
|
355
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2016 |
Chronic infection with HIV
|
disease |
|
Disease or Syndrome
|
48
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Myasthenia Gravis
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
293
|
28
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Adult type dermatomyositis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
218
|
31
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Flavivirus Infections
|
group |
Infections
|
Disease or Syndrome
|
29
|
|
0.020 |
None |
0.500 |
2 |
|
2003 |
2018 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
721
|
47
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2080
|
167
|
0.020 |
None |
1.000 |
2 |
|
1995 |
2000 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1497
|
388
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2018 |
Dermatomyositis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
227
|
33
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2325
|
197
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2000 |
Hepatitis B
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1382
|
269
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Familial Atypical Mole Melanoma Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
21
|
3
|
0.020 |
None |
1.000 |
2 |
|
1994 |
1994 |
Systemic Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
904
|
157
|
0.020 |
None |
1.000 |
1 |
|
2008 |
2019 |